366-02-003 ISMRM Abstract

Based DTI study of visual pathway damage in demyelinating optic neuritis

Primary: Neuro - Neuroinflammation

Secondary: Brain Function and fMRI - fMRI & Neuromodulation

366-02-003 · Brain-Body Axis · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row G

Keywords: Diffusion Tensor Imaging Demyelinating optic neuritis Visual pathways

Accepted

yongbin li ¹, lu zhang²

¹Xi‘an NO.1 Hospital, Xi'an, China

²Xi‘an NO.9 Hospital, China

Presenting Author: yongbin li

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. [1] Gao C, Zhuo Z, Duan Y, Yao Y, Su L, Zhang X, Song T. Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD. Front Neurol. 2021 Jun 9;12:673472. doi: 10.3389/fneur.2021.673472. PMID: 34177778; PMCID: PMC8220215. [doi] [pmid]

2. [2] Waxman SG. Multiple sclerosis as a neuronal disease. Arch Neurol. 2000 Jan;57(1):22-4. doi: 10.1001/archneur.57.1.22. PMID: 10634428. [doi] [pmid]

3. [3] Bells S, Longoni G, Berenbaum T, de Medeiros CB, Narayanan S, Banwell BL, Arnold DL, Mabbott DJ, Ann Yeh E. Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders. Neuroimage Clin. 2022;34:103001. doi: 10.1016/j.nicl.2022.103001. Epub 2022 Mar 31. PMID: 35381508; PMCID: PMC8980471. [doi] [pmid]

4. [4] Pawlitzki M, Horbrügger M, Loewe K, Kaufmann J, Opfer R, Wagner M, Al-Nosairy KO, Meuth SG, Hoffmann MB, Schippling S. MS optic neuritis-induced long-term structural changes within the visual pathway. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 22;7(2):e665. doi: 10.1212/NXI.0000000000000665. PMID: 32224498; PMCID: PMC7057062. [doi] [pmid]

5. [5] Klistorner A, Triplett JD, Barnett MH, Yiannikas C, Barton J, Parratt J, You Y, Graham SL. Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies. J Clin Neurophysiol. 2021 May 1;38(3):186-191. doi: 10.1097/WNP.0000000000000757. PMID: 33235179. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/366-02-003